0001607062-16-000655.txt : 20160212 0001607062-16-000655.hdr.sgml : 20160212 20160212161025 ACCESSION NUMBER: 0001607062-16-000655 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160209 FILED AS OF DATE: 20160212 DATE AS OF CHANGE: 20160212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brusegard David CENTRAL INDEX KEY: 0001516920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 161419139 MAIL ADDRESS: STREET 1: 4145 NORTH SERVICE ROAD, SUITE 200 CITY: BURLINGTON STATE: A6 ZIP: L7L6A3 4 1 brusegard021216form4.xml FORM 4 X0306 4 2016-02-09 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001516920 Brusegard David 4145 NORTH SERVICE ROAD, SUITE 200 BURLINGTON A6 L7L6A3 ONTARIO, CANADA 0 1 0 0 Chief Operating Officer Common Stock 2016-02-09 4 M 0 5583775 0.001 A 3916104 D Common Stock Purchase Option 0.001 2016-02-09 4 M 0 546448 0 D 2012-06-20 2017-06-19 Common Stock 546448 0 D Common Stock Purchase Option 0.001 2016-02-09 4 M 0 1928925 0 D 2013-04-01 2018-04-01 Common Stock 1928925 0 D Common Stock Purchase Option 0.001 2016-02-09 4 M 0 595239 0 D 2013-06-06 2018-06-06 Common Stock 595239 0 D Common Stock Purchase Option 0.001 2016-02-09 4 M 0 845492 0 D 2014-01-01 2018-10-31 Common Stock 845942 0 D Common Stock Purchase Option 0.001 2016-02-09 4 M 0 1667671 0 A 2016-02-09 2020-10-26 Common Stock 1667671 1667671 D /s/ Dr. David Brusegard, PhD 2016-02-09